Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › FGF21 compound / GLP-1R agonist combinations with optimized activity ratio

FGF21 compound / GLP-1R agonist combinations with optimized activity ratio

US Patent 10583174 · Granted Mar 10, 2020

Estimated economic value: $11,366,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof wi2024
FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof wi2024
FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof wi2024
Multispecific antibodies facilitating selective light chain pairing2023
PseudoFab-based multispecific binding proteins2023
FGF21 variants2022
FGF21 variants2022
FGF21 variants2022
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjug2020
Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic ac2020